Baroda BNP Paribas Mid cap Fund
The Scheme seeks to generate long-term capital appreciation by investing primarily in companies with high growth opportunities in the mid capitalization segment. The fund will emphasize on companies that appear to offer opportunities for long-term growth and will be inclined towards companies that are driven by dynamic style of management and entrepreneurial flair.
Growthvine rating: 3/5 — ranked #9 of 34 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹108.70 (as of 2026-09-25) |
|---|
| AUM | ₹2,658 Cr |
|---|
| Expense ratio | 1.70% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Ankeet Pandya |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| Sharpe ratio | 0.74 |
|---|
| Standard deviation | 15.39% |
|---|
| Max drawdown | −19.11% |
|---|
| Alpha | 1.34 |
|---|
| Beta | 0.85 |
|---|
Over 5 years, captured 83.1% of NIFTY Midcap 150's upside and 79.9% of its downside.
Market cap allocation
| Large cap | 12.9% |
|---|
| Mid cap | 71.5% |
|---|
| Small cap | 15.6% |
|---|
Concentration
| Top 5 holdings | 13.1% |
|---|
| Top 10 holdings | 22.6% |
|---|
| Total holdings | 73 |
|---|
| Index overlap | 41.9% |
|---|
| Active share | 58.1% |
|---|
Top holdings
- Bharat Heavy Electricals Ltd. — 3.3%
- Clearing Corporation of India Ltd — 3.2%
- GE Vernova T&D India Limited — 2.8%
- PB Fintech Limited — 2.5%
- Indian Bank — 2.4%
- Ipca Laboratories Ltd. — 2.2%
- Federal Bank Ltd. — 2.0%
- ACUTAAS CHEMICALS LIMITED — 2.0%
- Multi Commodity Exchange of India Ltd — 1.9%
- One 97 Communications Limited — 1.9%
Top sectors
- Banking & Financial — 17.9%
- Pharma & Biotech — 9.5%
- Automobile — 9.3%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 3.7% | Q3 | #17 of 31 |
| 2025 | 2.5% | Q2 | #13 of 29 |
| 2024 | 28.5% | Q3 | #17 of 29 |
| 2023 | 32.6% | Q4 (Bottom) | #22 of 28 |